The European Central Bank announced that it would cut three key interest rates in the euro zone. On the 12th local time, the European Central Bank held a monetary policy meeting at its headquarters in Frankfurt, Germany, and decided to cut all three key interest rates by 25 basis points. This is also the fourth time that the European Central Bank cut interest rates this year after it announced a rate cut in June this year. According to the latest interest rate resolution announced by the European Central Bank, the deposit mechanism interest rate is reduced to 3.0%, the main refinancing interest rate is reduced to 3.15%, and the marginal lending interest rate is reduced to 3.40%. (CCTV News)The Nikkei 225 index just broke through the 40000.00 mark, and the latest report was 40000.43, up 1.60% in the day.Huachuang Securities: It was first rated as "recommended" by Zangge Mining, with a target price of 33.3 yuan. Huachuang Securities Research Report pointed out that Zangge Mining (000408.SZ) is an important producer of potassium lithium salt and copper in China, with a high dividend return to shareholders. The company actively arranges high-quality potash resources at home and abroad: three major projects, namely, Heibei potash mine in Dalangtan, Alkali-Shishan potash mine and the eastern part of deep brine potash mine in Xiaoliangshan-Dafengshan area, are steadily promoted in China, with a total exploration right of 1,400 square kilometers; Overseas has signed a potash exploration agreement with Laos. At present, the exploration report and potash mine reserve certificate have been obtained. It is estimated that the total amount of potassium chloride resources in Setani County and Ba 'e County is 984 million tons. It is estimated that the output of the first phase of potassium chloride project will be 1 million tons/year, and the scale of potassium chloride production is expected to double in the future. The company is an important manufacturer of potassium and lithium in China, and Julong Copper is expected to inject strong kinetic energy into the company's growth. Considering that Mamicho Mining has not been consolidated at present, it is estimated that the company will realize a net profit of 25.0/27.7/4.29 billion yuan in 24-26 years, which is -27%, +11% and +54.9% respectively. In 2025, it can be compared with the company's average valuation of 19 times, giving the company a valuation of 19 times in 2025, corresponding to the target price of 33.3 yuan, covering for the first time and giving a "recommended" rating.
Guan Qingyou: I am optimistic about the stock market by cutting interest rates and lowering the RRR. For example, Guan Qingyou, president and chief economist of the Financial Research Institute, said that lowering the RRR and raising interest rates will definitely happen, and from the downward trend of previous interest rates, it should be faster. Regarding the current market conditions, Guan Qingyou said that different subjects have different judgments on the market trend in one or two trading days, but he is still optimistic, and said that the positive impact of the current policy change on the capital market cannot be underestimated. Combining industrial structure and policy orientation, Guan Qingyou said that consumer companies, technology companies, and mergers and acquisitions involving the transformation and upgrading of traditional industries to emerging formats are all his optimistic directions. In addition, for the economic growth target in 2025, Guan Qingyou believes that "the target of 5% can still be contested". He also said that 2025 will be better than 2024. "In 2025, the adjustment of policies will bring more increments to the market and industry." (sohu finance)The latest collection price of the heavy anticancer star drug Regofibril has dropped to a minimum of more than 4 yuan per tablet. The reporter learned at the scene of the tenth batch of drug collection that the anti-tumor drug Regofibril tablets with annual sales of more than 1 billion yuan have been auctioned by this collection, and the price has almost dropped to between 4 yuan and 6 yuan, which is 90% lower than the price limit. Nanjing Zhengda Tianqing is expected to win the bid in the first round of quotation. Regofibril can treat colorectal cancer, liver cancer and other cancers. Its original research manufacturer is Bayer, which occupies almost all the market share in China. The price of this collection is about 172 yuan per tablet. (science and technology innovation board Daily)COMEX silver fell 1.00% in the day and is now quoted at $32.63 per ounce.
Zhongzhiwei Technology completed tens of millions of yuan financing. On December 12th, Nanjing Zhongzhiwei Information Technology Co., Ltd. (Zhongzhiwei Technology) completed tens of millions of yuan B1 financing, which was jointly invested by Guangzhou Baiyun Financial Holding Group Co., Ltd. and Beijing Hongfeng Private Equity Fund Management Co., Ltd. This round of financing funds will be used for iterative application of AI+ network security products, breakthrough in key industry landing scenarios and market channel construction. Zhongzhiwei Technology is a solution provider of "city-level data+digital security operation", and has launched a series of new platform-based network security products around AISecOps (artificial intelligence security operation).The European Central Bank gave up the idea of keeping interest rates "restrictive".Domestic futures opened mixed at night, with Shanghai copper down 0.56%, Shanghai zinc down 0.39%, Shanghai nickel up 1.75%, iron ore up 0.06%, coking coal up 0.42% and crude oil up 1.15%.